#BIO2017: A Peek at Pavilions | FRANCE

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring you an insider’s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention.

To France, You Are Family

Pierre Goffaux and his fellow Business France executive Charles-Henry Dion exude a certain, how shall we say – savoir-faire, as they engaged in a conversation recently about their plans for the 4,000 square foot French Pavilion they will be hosting at the BIO International Convention in June.  The hour-long tete-a-tete, which could have easily gone on longer due to the Messrs.’ depth of understanding about their country’s global and partnering intentions, shed important light on how France will stand out in San Diego.

But first things first: French wine and cheese.

“On Sunday evening, before the craziness and excitement of BIO begins, we are inviting everyone at BIO to an informal reception hosted by Business France,” invites Mr. Dion. “The idea is to not only give a very brief overview of France’s seven biotech clusters by identifying their different therapeutic areas of specialty, but also to enjoy some French wines, cheeses, and pâtisserie in a relaxed environment.”  The event will be held at El Camino Real and bus shuttles will be provided from the convention center.

This will be Business France’s tenth year hosting a BIO International Pavilion. “We want the pavilion to genuinely represent France – and to do that we have expanded the exhibit space into a more mixed model,” explains Mr. Dion. “In previous years our pavilion was dedicated to the different French clusters, and although that is still the case, this year’s clusters will include small or start-up resident companies that present some of the successful work being accomplished in a particular region.”

The pavilion will also be host to two established French companies: Genosafe and Yposkesi along with Pact & Partners, a leading global executive search firm dedicated to life sciences.

“Business France exists to optimize the presence of everybody. We are open to all companies – from the smallest start up to some of the biggest names in therapeutics. In that respect we are a family and our updated exhibit model now reflects that sentiment.” You don’t have to be French to be in the family, however—the country’s extraordinary tax credits for R&D enable a company of any nationality, even with only one employee in France, to become eligible for a corporate tax reduction of 30% of R&D spending up to €100 million, and 5% on anything over that. So far roughly 16,000 companies have enjoyed the tax credit, which is largely considered the best in the world, representing a cumulative €6 billion.

Hefty incentives for innovation in R&D also exist by way of JEI, designed to assist innovative SMEs and new companies in need of immediate research tax credits. To acquire the JEI status and learn more click here.

Charles-Henry Dion, Senior Manager, North American Biotech & Healthcare Department

“Family” describes well the tone set by Mssrs. Dion and Goffaux as they eagerly explain their plans for the Convention, which include a presentation on Wednesday at 11:45 in the Global Innovation Hub, and, at informal gatherings with Australia, Brazil, and Canada.

Business France sees great opportunities in Australia, where together with AusBiotech, they will co-host a webinar in May that will help French companies better understand the Australian life sciences market and its business opportunities. The webinar also aims to introduce both national delegations before the convention in order to generate further partnering meetings and networking.

Biotech in Brazil has become a top priority since that country’s recent legislative changes. Business France was quick to respond to their colleagues in San Paulo when asked to discuss partnering opportunities. Together, they have organized a social hour for companies from each region to meet for a relaxed chat at the French pavilion.

Pierre Goffaux, Project Manager, Biotech & Healthcare Department

As for Canada, Mr. Dion has this to say: “There is a tight bond between France and Canada, especially with Québec. But beyond that there are many business and educational exchanges including the recent partnership between our Lyon and Montreal clusters.” The two have agreed to join forces in order to provide enhanced support to companies seeking to expand on both sides of the Atlantic, with a full immersion in the local ecosystem, including support, a personalized course of action, and office space.

The pièce de résistance? As is true for all of the events hosted by Business France during the BIO International Convention, everyone, from the intimate gatherings with specific countries, to the Welcome Reception on Sunday night, is invited. And, yes, bring your willpower (or not!) because in addition to meeting and conversing, you will be tempted to indulge some of France’s finest délicatesses.

#BIO2017: A Peek at Pavilions | FRANCE

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring you an insider’s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention.

To France, You Are Family

Pierre Goffaux and his fellow Business France executive Charles-Henry Dion exude a certain, how shall we say – savoir-faire, as they engaged in a conversation recently about their plans for the 4,000 square foot French Pavilion they will be hosting at the BIO International Convention in June.  The hour-long tete-a-tete, which could have easily gone on longer due to the Messrs.’ depth of understanding about their country’s global and partnering intentions, shed important light on how France will stand out in San Diego.

But first things first: French wine and cheese.

“On Sunday evening, before the craziness and excitement of BIO begins, we are inviting everyone at BIO to an informal reception hosted by Business France,” invites Mr. Dion. “The idea is to not only give a very brief overview of France’s seven biotech clusters by identifying their different therapeutic areas of specialty, but also to enjoy some French wines, cheeses, and pâtisserie in a relaxed environment.”  The event will be held at El Camino Real and bus shuttles will be provided from the convention center.

This will be Business France’s tenth year hosting a BIO International Pavilion. “We want the pavilion to genuinely represent France – and to do that we have expanded the exhibit space into a more mixed model,” explains Mr. Dion. “In previous years our pavilion was dedicated to the different French clusters, and although that is still the case, this year’s clusters will include small or start-up resident companies that present some of the successful work being accomplished in a particular region.”

The pavilion will also be host to two established French companies: Genosafe and Yposkesi along with Pact & Partners, a leading global executive search firm dedicated to life sciences.

“Business France exists to optimize the presence of everybody. We are open to all companies – from the smallest start up to some of the biggest names in therapeutics. In that respect we are a family and our updated exhibit model now reflects that sentiment.” You don’t have to be French to be in the family, however—the country’s extraordinary tax credits for R&D enable a company of any nationality, even with only one employee in France, to become eligible for a corporate tax reduction of 30% of R&D spending up to €100 million, and 5% on anything over that. So far roughly 16,000 companies have enjoyed the tax credit, which is largely considered the best in the world, representing a cumulative €6 billion.

Hefty incentives for innovation in R&D also exist by way of JEI, designed to assist innovative SMEs and new companies in need of immediate research tax credits. To acquire the JEI status and learn more click here.

Charles-Henry Dion, Senior Manager, North American Biotech & Healthcare Department

“Family” describes well the tone set by Mssrs. Dion and Goffaux as they eagerly explain their plans for the Convention, which include a presentation on Wednesday at 11:45 in the Global Innovation Hub, and, at informal gatherings with Australia, Brazil, and Canada.

Business France sees great opportunities in Australia, where together with AusBiotech, they will co-host a webinar in May that will help French companies better understand the Australian life sciences market and its business opportunities. The webinar also aims to introduce both national delegations before the convention in order to generate further partnering meetings and networking.

Biotech in Brazil has become a top priority since that country’s recent legislative changes. Business France was quick to respond to their colleagues in San Paulo when asked to discuss partnering opportunities. Together, they have organized a social hour for companies from each region to meet for a relaxed chat at the French pavilion.

Pierre Goffaux, Project Manager, Biotech & Healthcare Department

As for Canada, Mr. Dion has this to say: “There is a tight bond between France and Canada, especially with Québec. But beyond that there are many business and educational exchanges including the recent partnership between our Lyon and Montreal clusters.” The two have agreed to join forces in order to provide enhanced support to companies seeking to expand on both sides of the Atlantic, with a full immersion in the local ecosystem, including support, a personalized course of action, and office space.

The pièce de résistance? As is true for all of the events hosted by Business France during the BIO International Convention, everyone, from the intimate gatherings with specific countries, to the Welcome Reception on Sunday night, is invited. And, yes, bring your willpower (or not!) because in addition to meeting and conversing, you will be tempted to indulge some of France’s finest délicatesses.

#BIO2017: A Peek at Pavilions | CANADA

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring an insider’s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention.

Keeping Up with the Canadians

Thriving commercialization is Canada’s buzz phrase this year as the country prepares for another massive showing at the BIO International Convention where nearly 800 delegates – second only in size to the United States – will showcase their renewed and ever-expanding investment in biotechnology. Ministers and Members of Parliament from each of the provinces, alongside industry powerhouses, will share plans about how, and why, Canada is becoming one of the great destinations for investment capital in the world.

“One of the great competitive advantages Canada enjoys is its proximity to the United States, our largest market and trading partner” observed BIOTECanada President and CEO Andrew Casey, “there can be some challenges in this relationship but on the whole there is a huge benefit to having the biggest pool of investment capital right next door.  Coupled with other commonalities including: a like-minded business culture; similar patient population; and, the benefit of speaking the same language, Canada’s competitive position globally is clearly enhanced.”

Despite the country’s poignant likenesses and mutual affection however, Mr. Casey is quick to point out distinctions too. “We have a population of 36 million or so – about the population of California – spread across the country. Our major urban centers are Montreal, Toronto and Vancouver; after that you get into populations of under a million people per city, and yet, when you look across the country which spans nearly 3,500 miles, you see biotech clusters in pretty much each of the 10 provinces.”

These organically populated clusters are centered among hospitals and universities that support one another across the vast region; so unlike Cambridge or San Francisco where clusters are densely compact, the Canadian clusters take on a virtual component rather than geographical.  As a result, diverse, open innovation and collaboration is widespread.

“Our focus now,” according to Mr. Casey, “is to commercialize the great ideas emerging from our universities and research hospitals, scale them up, and turn them into globally competitive Canadian-based companies. Once we get a company across the finish line – and we’re very close — it will attract more interest and investors, and entrepreneurs“.

And that’s precisely why the BIO International Convention is so important to Canada. “We try, as a country, to attract new investors and companies, and likewise, we don’t want our existing companies and investors to go to other jurisdictions.” Mr. Casey readily admits that in this respect, Canada is no different from other countries, saying that’s the impetus behind the hefty investment to attend the Convention. “BIO is where the world is. Being there is about relationship building, relationship maintenance; it’s about checking in and showing milestones being reached. Our political representatives certainly understand the significance of this dynamic.”

Recently, BIOTECanada congratulated the partnership between Versant Ventures and Bayer AG on their near historic investment, Blue Rock Therapeutics, Canada’s newest stem-cell research company. “The creation of Blue Rock represents the new biotech commercialization model, one that requires a diverse and collaborative ecosystem, and includes investors and multinational partners. The corresponding financial commitment sends a very strong signal to the global investment community that the Canadian biotech ecosystem is thriving.”

The inviting Canadian appeal has also caught the attention of JLabs, an entirely unique early discovery model designed to help entrepreneurs take science and turn it into profits. With seven of their eight locations in the United States, it should come as no surprise that JLabs chose Canada for the eighth facility; their first outside of the United States.

To learn more visit the Canadian Pavilion at the upcoming BIO International Convention, June 19-22, 2017 in San Diego where you will find:

June 20

10:30am: Pavilion opening
Government Officials & key industry leaders, the Royal Canadian Mounted Police and Canadian delegates are present for the official opening of the Canadian Pavilion.

Afternoon: Coast to Coast Competition
BIOTECanada and Wilson Sonsini Goodrich & Rosati present the Annual Coast to Coast Competition. This provides 6-8 emerging companies the opportunity to present to a panel of investors and key industry executives and receive feedback. The winner receives a presentation spot in the 2018 BIOTECanada Investor Summit.

Afternoon: The Next 150 Years of Canadian Innovation

As Canada celebrates its 150th birthday, the federal government has committed to a competitive innovation policy.  Aimed at building on existing expertise in 21st century technologies with a skilled labor force, creating innovation hubs and incentivizing investment, all intended to compete in the global marketplace of discovery and commercialization.  The panel will explore these new initiatives, while addressing gaps and opportunities.

June 21

New this year, BIOTECanada will host the ecosystem showcase which will highlight the PATH to innovation. This will consist of armchair discussions identifying industry strengths regarding Pipeline, Accelerator/ Incubator, Transferring knowledge, Health Partners.

To participate in any of these events contact Julie Mair

Athena Staton serves as executive editor for BIO Buzz, the Official Show Daily for the BIO International Convention, and BIO’s Breaking Buzz blog series.

#BIO2017: A Peek at Pavilions | CANADA

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring an insider’s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention.

Keeping Up with the Canadians

Thriving commercialization is Canada’s buzz phrase this year as the country prepares for another massive showing at the BIO International Convention where nearly 800 delegates – second only in size to the United States – will showcase their renewed and ever-expanding investment in biotechnology. Ministers and Members of Parliament from each of the provinces, alongside industry powerhouses, will share plans about how, and why, Canada is becoming one of the great destinations for investment capital in the world.

“One of the great competitive advantages Canada enjoys is its proximity to the United States, our largest market and trading partner” observed BIOTECanada President and CEO Andrew Casey, “there can be some challenges in this relationship but on the whole there is a huge benefit to having the biggest pool of investment capital right next door.  Coupled with other commonalities including: a like-minded business culture; similar patient population; and, the benefit of speaking the same language, Canada’s competitive position globally is clearly enhanced.”

Despite the country’s poignant likenesses and mutual affection however, Mr. Casey is quick to point out distinctions too. “We have a population of 36 million or so – about the population of California – spread across the country. Our major urban centers are Montreal, Toronto and Vancouver; after that you get into populations of under a million people per city, and yet, when you look across the country which spans nearly 3,500 miles, you see biotech clusters in pretty much each of the 10 provinces.”

These organically populated clusters are centered among hospitals and universities that support one another across the vast region; so unlike Cambridge or San Francisco where clusters are densely compact, the Canadian clusters take on a virtual component rather than geographical.  As a result, diverse, open innovation and collaboration is widespread.

“Our focus now,” according to Mr. Casey, “is to commercialize the great ideas emerging from our universities and research hospitals, scale them up, and turn them into globally competitive Canadian-based companies. Once we get a company across the finish line – and we’re very close — it will attract more interest and investors, and entrepreneurs“.

And that’s precisely why the BIO International Convention is so important to Canada. “We try, as a country, to attract new investors and companies, and likewise, we don’t want our existing companies and investors to go to other jurisdictions.” Mr. Casey readily admits that in this respect, Canada is no different from other countries, saying that’s the impetus behind the hefty investment to attend the Convention. “BIO is where the world is. Being there is about relationship building, relationship maintenance; it’s about checking in and showing milestones being reached. Our political representatives certainly understand the significance of this dynamic.”

Recently, BIOTECanada congratulated the partnership between Versant Ventures and Bayer AG on their near historic investment, Blue Rock Therapeutics, Canada’s newest stem-cell research company. “The creation of Blue Rock represents the new biotech commercialization model, one that requires a diverse and collaborative ecosystem, and includes investors and multinational partners. The corresponding financial commitment sends a very strong signal to the global investment community that the Canadian biotech ecosystem is thriving.”

The inviting Canadian appeal has also caught the attention of JLabs, an entirely unique early discovery model designed to help entrepreneurs take science and turn it into profits. With seven of their eight locations in the United States, it should come as no surprise that JLabs chose Canada for the eighth facility; their first outside of the United States.

To learn more visit the Canadian Pavilion at the upcoming BIO International Convention, June 19-22, 2017 in San Diego where you will find:

June 20

10:30am: Pavilion opening
Government Officials & key industry leaders, the Royal Canadian Mounted Police and Canadian delegates are present for the official opening of the Canadian Pavilion.

Afternoon: Coast to Coast Competition
BIOTECanada and Wilson Sonsini Goodrich & Rosati present the Annual Coast to Coast Competition. This provides 6-8 emerging companies the opportunity to present to a panel of investors and key industry executives and receive feedback. The winner receives a presentation spot in the 2018 BIOTECanada Investor Summit.

Afternoon: The Next 150 Years of Canadian Innovation

As Canada celebrates its 150th birthday, the federal government has committed to a competitive innovation policy.  Aimed at building on existing expertise in 21st century technologies with a skilled labor force, creating innovation hubs and incentivizing investment, all intended to compete in the global marketplace of discovery and commercialization.  The panel will explore these new initiatives, while addressing gaps and opportunities.

June 21

New this year, BIOTECanada will host the ecosystem showcase which will highlight the PATH to innovation. This will consist of armchair discussions identifying industry strengths regarding Pipeline, Accelerator/ Incubator, Transferring knowledge, Health Partners.

To participate in any of these events contact Julie Mair

Athena Staton serves as executive editor for BIO Buzz, the Official Show Daily for the BIO International Convention, and BIO’s Breaking Buzz blog series.